Jorge Colon Morales
Independent Medical Examiner Bayamon, PR Medical Doctor
NPI 1265685218 CMS profile 599063
Ave Santa Juanita, Plaza Santa Juanita M-71, Bayamon, PR 00956
General payments
$22
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Jorge Colon Morales of Bayamon, PR is reported in the CMS Open Payments database as having received $22 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $22 | 1 |
Beside peers
- Jorge Colon Morales
- Independent Medical Examiner median
- Middle half of Independent Medical Examiner
- National median
In program year 2019, general payments to Jorge Colon Morales were reported at $0. Among 21 Independent Medical Examiner profiles paid that year, the median was $113 and the middle half received between $25 and $528.
Show as a table
| Year | Jorge Colon Morales | Independent Medical Examiner median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $113 | $25–$528 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | — | — | $132 |
| 2022 | $0 | — | — | $149 |
| 2023 | $0 | — | — | $160 |
| 2024 | $0 | — | — | $164 |
| 2025 | $22 | — | — | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 67 drugsPart D claims
4,164
Drug cost
$237,896
Branded share of claims
26.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Trulicity Dulaglutide | Brand | 86 | $83,978 | |
| Jardiance Empagliflozin | Brand | 134 | $70,492 | |
| Eliquis Apixaban | Brand | 42 | $23,813 | |
| Entresto Sacubitril/Valsartan | Brand | 12 | $8,069 | |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | Brand | 121 | $7,978 | |
| Farxiga Dapagliflozin Propanediol | Brand | 12 | $6,585 | |
| Ulticare Pen Needle Pen Needle, Diabetic | Brand | 67 | $4,155 | |
| Advair Diskus Fluticasone Propion/Salmeterol | Brand | 18 | $3,878 | |
| Novolog Flexpen Insulin Aspart | Brand | 25 | $3,294 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 95 | $2,964 |
The 10 drugs with the highest cost, of 67 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 12 billing codesPaid by Medicare
$21,080
Medicare patients
131
Services billed
394
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 69% | |
| Arthritis | 36% | |
| Chronic kidney disease | 34% | |
| Ischemic heart disease | 24% | |
| Heart failure | 18% | |
| Depression | 12% | |
| Osteoporosis | 10% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Independent Medical Examiner in Puerto Rico
Angela Torres Torres
Independent Medical Examiner · Ponce, PR
Eileen Quinones
Independent Medical Examiner · Hormigueros, PR
Ramon Torres Vega
Independent Medical Examiner · Lares, PR
Ferdinand Feliciano
Independent Medical Examiner · Cayey, PR
Ayleen Roman-Cruz
Independent Medical Examiner · Arecibo, PR
Related records
Independent Medical Examiner in Puerto Rico
Practitioners in the same specialty and state, ranked by reported value.
All Independent Medical Examiner
Everyone recorded under this specialty, nationwide.
Doctors in Puerto Rico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.